Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pien Tze Huang Capsules in mid-late stage primary liver cancer
ChiCTR-IPR-17010446Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Jan 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Pien Tze Huang in hepatocellular carcinoma (HCC) (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: Liver function and Cancer pain. Started Jan 2017; status: recruiting.
02
Drugs
Pien Tze Huang
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-IPR-17010446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010446.